Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cultural Diversity | 1 | 2021 | 365 | 0.590 |
Why?
|
Health Personnel | 6 | 2022 | 3310 | 0.490 |
Why?
|
Yellow Fever | 1 | 2014 | 54 | 0.440 |
Why?
|
Hepatitis A | 1 | 2014 | 132 | 0.440 |
Why?
|
Typhoid Fever | 1 | 2014 | 195 | 0.410 |
Why?
|
Integrin alpha4 | 1 | 2009 | 87 | 0.330 |
Why?
|
Travel | 1 | 2014 | 785 | 0.300 |
Why?
|
Vaccination | 2 | 2022 | 3361 | 0.220 |
Why?
|
Diabetic Retinopathy | 2 | 2009 | 1268 | 0.200 |
Why?
|
Masks | 1 | 2020 | 209 | 0.150 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
Massachusetts | 3 | 2021 | 8803 | 0.110 |
Why?
|
Blood-Retinal Barrier | 3 | 2009 | 62 | 0.110 |
Why?
|
Travel Medicine | 1 | 2014 | 83 | 0.110 |
Why?
|
Urban Population | 1 | 2021 | 2022 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 983 | 0.110 |
Why?
|
Rats, Long-Evans | 3 | 2009 | 378 | 0.110 |
Why?
|
Leukostasis | 2 | 2009 | 23 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1486 | 0.100 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6068 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2009 | 3484 | 0.090 |
Why?
|
Brazil | 1 | 2014 | 1218 | 0.090 |
Why?
|
Antibodies, Blocking | 1 | 2009 | 242 | 0.080 |
Why?
|
Needs Assessment | 1 | 2014 | 1139 | 0.070 |
Why?
|
Cell Adhesion | 3 | 2009 | 3094 | 0.070 |
Why?
|
Endotoxins | 2 | 2007 | 521 | 0.070 |
Why?
|
Prosthesis-Related Infections | 1 | 2012 | 487 | 0.070 |
Why?
|
Integrin alpha4beta1 | 1 | 2007 | 119 | 0.070 |
Why?
|
Uveitis, Anterior | 1 | 2007 | 102 | 0.070 |
Why?
|
Benzoquinones | 1 | 2007 | 198 | 0.070 |
Why?
|
Leukocytes | 3 | 2009 | 2026 | 0.070 |
Why?
|
Capillary Permeability | 1 | 2009 | 768 | 0.060 |
Why?
|
Ciliary Body | 1 | 2006 | 166 | 0.060 |
Why?
|
NF-kappa B | 3 | 2009 | 2488 | 0.060 |
Why?
|
Lactams, Macrocyclic | 1 | 2007 | 315 | 0.060 |
Why?
|
Up-Regulation | 3 | 2009 | 4122 | 0.060 |
Why?
|
Inhibin-beta Subunits | 1 | 2004 | 27 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3804 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2007 | 423 | 0.060 |
Why?
|
Pigment Epithelium of Eye | 1 | 2004 | 209 | 0.060 |
Why?
|
Retinal Vessels | 1 | 2009 | 836 | 0.050 |
Why?
|
Uveitis | 1 | 2007 | 393 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1112 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 444 | 0.050 |
Why?
|
Activins | 1 | 2004 | 211 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Integrins | 1 | 2007 | 839 | 0.050 |
Why?
|
Corneal Neovascularization | 1 | 2004 | 185 | 0.050 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2012 | 1406 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9280 | 0.050 |
Why?
|
Ageusia | 1 | 2020 | 19 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2009 | 4357 | 0.050 |
Why?
|
Endothelium, Vascular | 2 | 2009 | 4433 | 0.040 |
Why?
|
Rats | 4 | 2009 | 23711 | 0.040 |
Why?
|
Photochemotherapy | 1 | 2006 | 820 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2020 | 131 | 0.040 |
Why?
|
Middle Aged | 5 | 2021 | 220352 | 0.040 |
Why?
|
Male | 8 | 2021 | 359744 | 0.040 |
Why?
|
Pharyngitis | 1 | 2020 | 220 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 224 | 0.040 |
Why?
|
Nasopharynx | 1 | 2020 | 394 | 0.040 |
Why?
|
Risk Factors | 2 | 2021 | 74359 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
Body Temperature | 1 | 2020 | 777 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2282 | 0.040 |
Why?
|
Virulence | 1 | 2020 | 1298 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2004 | 1928 | 0.030 |
Why?
|
Glaucoma | 1 | 2006 | 1182 | 0.030 |
Why?
|
Cornea | 1 | 2004 | 1326 | 0.030 |
Why?
|
Female | 7 | 2021 | 391270 | 0.030 |
Why?
|
Biological Evolution | 1 | 2020 | 1074 | 0.030 |
Why?
|
Humans | 11 | 2022 | 760621 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2640 | 0.030 |
Why?
|
Adult | 5 | 2021 | 219994 | 0.030 |
Why?
|
Fever | 1 | 2020 | 1617 | 0.030 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2007 | 687 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 24123 | 0.030 |
Why?
|
Yogurt | 1 | 2012 | 71 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2007 | 621 | 0.020 |
Why?
|
Cohort Studies | 2 | 2021 | 41335 | 0.020 |
Why?
|
Animals | 6 | 2009 | 167963 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18137 | 0.020 |
Why?
|
Retinal Vasculitis | 1 | 2007 | 46 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12159 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2007 | 2864 | 0.020 |
Why?
|
Tonometry, Ocular | 1 | 2006 | 235 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13314 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2006 | 622 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 691 | 0.010 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2004 | 149 | 0.010 |
Why?
|
Porphyrins | 1 | 2006 | 353 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 295 | 0.010 |
Why?
|
Eye Proteins | 1 | 2007 | 633 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 2004 | 321 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21392 | 0.010 |
Why?
|
Cell Count | 1 | 2006 | 1835 | 0.010 |
Why?
|
Photosensitizing Agents | 1 | 2006 | 618 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1347 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2021 | 80372 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 642 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2007 | 931 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2007 | 998 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2004 | 1126 | 0.010 |
Why?
|
Intraocular Pressure | 1 | 2006 | 1288 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8552 | 0.010 |
Why?
|
Retinal Ganglion Cells | 1 | 2006 | 806 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5039 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1246 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 1974 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2007 | 2440 | 0.010 |
Why?
|
Cell Membrane | 1 | 2007 | 3682 | 0.010 |
Why?
|
Phosphorylation | 1 | 2007 | 8313 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 2448 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10827 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5785 | 0.010 |
Why?
|
Signal Transduction | 2 | 2007 | 23376 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2004 | 3663 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4490 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2007 | 7850 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9185 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20509 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2004 | 18957 | 0.000 |
Why?
|
Mice | 2 | 2006 | 81208 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22023 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58995 | 0.000 |
Why?
|
Time Factors | 1 | 2007 | 40165 | 0.000 |
Why?
|
Transcription Factors | 1 | 2004 | 12103 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_